[1]苏静怡. 山莨菪碱(6542)抗体休克作用机制的研究进展\[J\]. 生理科学进展, 1985, 16(4): 317-322.
[2]Poupko JM, Baskin SI, Moore E. The pharmacological properties of anisodamine\[J\]. J Appl Toxicol, 2007, 27(2): 116-121.
[3]Eisenkraft A, Falk A. Possible role for anisodamine in organophosphate poisoning\[J\]. Br J Pharmacol, 2016, 173(11): 1719-1727.
[4]Du X, Liu H, Yue Y, et al. Anisodamine hydrobromide protects glycocalyx and against the lipopolysaccharideinduced increases in microvascular endothelial layer permeability and nitric oxide production \[J\]. Cardiovasc Eng Technol, 2020,9:486-493.
[5]Leskova GF, Su LB, Udovichenko VI. The effect of anisodamine on lipoprotein metabolism in the liver and the plasma membrane phospholipids of the hepatocytes in hemorrhagic shock\[J\]. Patol Fiziol Eksp Ter, 1990, 34(1): 15-17.
[6]杨国栋, 周文华, 徐飞, 等. 山莨菪碱对红细胞膜流动性和膜内源荧光的影响\[J\]. 现代应用药学, 1993, 10(1): 4-6.
[7]Hwang F, Wang SM, Hu CC. The disordering effect of hyoscyamine drugs on phospholipid membranes\[J\]. Biochim Biophys Acta, 1983, 736(2): 220-225.
[8]王苏民, 傅亚珍, 李跃贞, 等. 莨菪类药物对人工膜相变行为的影响\[J\]. 中国药理学报, 1986, 7(2): 114-116.
[9]Wang PY, Chen JW, Hwang F. Anisodamine causes acyl chain interdigitation in phosphatidylglycerol\[J\]. FEBS Lett, 1993, 332(1-2): 193-196.
[10]Masaki N, Ohta Y, Shirataki H, et al. Hepatocyte membrane stabilization by prostaglandins E1 and E2: favorable effects on rat liver injury\[J\]. Gastroenterology, 1992, 102(2): 572-576.
[11]姚秀娟, 崔毅, 于宝蓉, 等. 山莨菪碱对麻醉大鼠缺血再灌注心律失常和脂质过氧化的保护\[J\]. 第四军医大学学报, 1992, 13(5): 349-352.
[12]姚秀娟, 谭月华, 许自超, 等. 山莨菪碱对心肌缺血再灌注损伤的作用与抗脂质过氧化(英文)\[J\]. 中国药理学报, 1995, 16(2): 58-61.
[13]刘磊, 张学梅, 范劲松. 山莨菪碱清除氧自由基和抗脂质过氧化作用\[J\]. 大连大学学报, 1995, 5(3): 385-391.
[14]唐兆新, 李培英, 王炫英, 等. 山羊内毒素休克诱发脂质过氧化作用及山莨菪碱对其影响的研究\[J\]. 畜牧兽医学报, 1998, 29(2): 3-5.
[15]阳冠明,黄伟民,叶司原,等. 山莨菪碱抗脂质过氧化的研究\[J\]. 广西医科大学学报, 1996, 12(2): 12-14.
[16]Wan F, Du X, Liu H, et al. Protective effect of anisodamine hydrobromide on lipopolysaccharideinduced acute kidney injury\[J\]. Biosci Rep, 2020, 40(7): BSR20201812.
[17]吴娟, 金曼, 黎笔熙. 胆碱能抗炎通路的作用机制及其器官保护作用\[J\]. 华南国防医学杂志, 2019, 33(8): 580-582,587.
[18]刘清香, 谢剑锋, 杨毅. 胆碱能抗炎通路对脓毒症调控机制的研究进展\[J\]. 中华危重病急救医学, 2019, 31(6): 781-784.
[19]Guo H, Lorenz RR, Vanhoutte PM. Anisodamine antagonizes acetylcholineinduced inhibition of adrenergic neurotransmission in the canine saphenous vein\[J\]. Chin Med Sci J, 1992, 7(1): 32-35.
[20]Guo HY, Loren RR, Vanhutte PM. Anisodamine inhibits acetylcholineinduced endotheliumdependent relaxation of canine femoral artery\[J\]. Chin Med J (Engl), 1992, 105(8): 666-670.
[21]Guo HY, Lorenz RR, Vanhoutte PM. Anisodamine inhibits nonselectively muscarinic receptors in isolated canine veins\[J\]. Chin Med J (Engl),1992,105(1): 5-10.
[22]Xu GN, Yang K, Xu ZP, et al. Protective effects of anisodamine on cigarette smoke extractinduced airway smooth muscle cell proliferation and tracheal contractility\[J\]. Toxicol Appl Pharmacol, 2012, 262(1): 70-79.
[23]Zhao CL, Ron S, Liu CG, et al. Blocking effect of anisodamine on acetylcholine receptor channels\[J\]. Acta Pharmacologica Sinica, 1993, 14(2): 190-192.
[24]Liu C, Shen FM, Le YY, et al. Anti shock effect of anisodamine involves a novel pathway for activating α7 nicotinic acetylcholine receptor\[J\]. Crit Care Med, 2009, 37(2): 634-641.
[25]Li Q, Lei H, Liu A, et al. The antishock effect of anisodamine requires the upregulation of α7 nicotine acetylcholine receptors by IL10\[J\]. Life Sci, 2011, 89(11-12): 395-401.
[26]Xu ZQ, Shao BZ, Ke P, et al. Combined administration of anisodamine and neostigmine rescued acute lethal crush syndrome through α7nAChRdependent JAK2STAT3 signaling\[J\]. Sci Rep, 2016, 6: 37709.
[27]Qian J, Zhang JM, Lin LL, et al. A combination of neostigmine and anisodamine protects against ischemic stroke by activating α7nAChR\[J\]. Int J Stroke, 2015, 10(5): 737-744.
[28]Xiu RJ, Hammerschmidt DE, Coppo PA, et al. Anisodamine inhibits thromboxane synthesis, granulocyte aggregation, and platelet aggregation. A possible mechanism for its efficacy in bacteremic shock\[J\]. JAMA, 1982, 247(10): 1458-1460.
[29]Fu Y, Gu XS, Hao GZ, et al. Comparison of myocardial microcirculatory perfusion after catheteradministered intracoronary thrombolysis with anisodamine versus standard thrombus aspiration in patients with STelevation myocardial infarction\[J\]. Catheter Cardiovasc Interv, 2019, 93(S1): 839-845.
[30]Zeng Y, Zhang XF, Fu BM, et al. The role of endothelial surface glycocalyx in mechanosensing and transduction\[J\]. Adv Exp Med Biol, 2018, 1097: 1-27.
[31]Zeng Y, Yao X, Liu X, et al. Antiangiogenesis triggers exosomes release from endothelial cells to promote tumor vasculogenesis\[J\]. J Extracell Vesicles, 2019, 8(1): 1629865.
[32]Flemming S, Burkard N, Renschler M, et al. Soluble VEcadherin is involved in endothelial barrier breakdown in systemic inflammation and sepsis\[J\]. Cardiovasc Res, 2015, 107(1): 32-44.
[33]ColásAlgora N, GarcíaWeber D, CachoNavas C, et al. Compensatory increase of VEcadherin expression through ETS1 regulates endothelial barrier function in response to TNFα\[J\]. Cell Mol Life Sci, 2020, 77(11): 2125-2140.
[34]Xiong S, Hong Z, Huang LS, et al. IL1β Suppression of VEcadherin transcription underlies sepsisinduced inflammatory lung injury\[J\]. J Clin Invest, 2020, 130(7): 3684-3698.
[35]Tarbell JM, Cancel LM. The glycocalyx and its significance in human medicine\[J\]. J Intern Med, 2016, 280(1): 97-113.
[36]Zeng Y, Waters M, Andrews A,et al. Fluid shear stress induces the clustering of heparan sulfate via mobility of glypican1 in lipid rafts\[J\]. Am J Physiol Heart Circ Physiol, 2013, 305(6): H811-820.
[37]Zeng Y, Tarbell JM. The adaptive remodeling of endothelial glycocalyx in response to fluid shear stress\[J\]. PLoS One, 2014, 9(1): e86249.
[38]Nikmanesh M, Shi ZD, Tarbell JM. Heparan sulfate proteoglycan mediates shear stressinduced endothelial gene expression in mouse embryonic stem cellderived endothelial cells\[J\]. Biotechnol Bioeng, 2012, 109(2): 583-594.
[39]Nikmanesh M, Cancel LM, Shi ZD, et al. Heparan sulfate proteoglycan, integrin, and syndecan4 are mechanosensors mediating cyclic strainmodulated endothelial gene expression in mouse embryonic stem cellderived endothelial cells\[J\]. Biotechnol Bioeng, 2019, 116(10): 2730-2741.
[40]Zhang L, Zeng M, Fan J, et al. Sphingosine-1-phosphate maintains normal vascular permeability by preserving endothelial surface glycocalyx in intact microvessels\[J\]. Microcirculation, 2016, 23(4): 301-310.
[41]Zeng Y, Adamson RH, Curry FR, et al. Sphingosine-1-phosphate protects endothelial glycocalyx by inhibiting syndecan1 shedding\[J\]. Am J Physiol Heart Circ Physiol, 2014, 306(3): H363-H372.
[42]Zeng Y, Liu XH, Tarbell J, et al. Sphingosine 1phosphate induced synthesis of glycocalyx on endothelial cells\[J\]. Exp Cell Res, 2015, 339(1): 90-95.
[43]Yen W, Cai B, Yang J, et al. Endothelial surface glycocalyx can regulate flowinduced nitric oxide production in microvessels in vivo\[J\]. PLoS One, 2015, 10(1): e0117133.
[44]Bartosch AMW, Mathews R, Tarbell JM. Endothelial glycocalyxmediated nitric oxide production in response to selective afm pulling\[J\]. Biophys J, 2017, 113(1): 101-108. |